To investigate the effect of NM23-H1 expression on remaining tumor receiving adjuvant therapy, we analyzed the correlation between NM23-H1 expression and clinical pathological factors in HNSCC patients with cervical metastases treated with postoperative radiotherapy. Here, NME1 is linked to head and neck squamous cell carcinoma.